Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Achieved $30 million milestone from Roche and Genentech for delivering a whole-genome map of microglial immune cells—the second neuro map ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

(RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a loss of 36 cents per share. The biotechnology company posted revenue of $5.2 ...

Decentralized finance platform Stream Finance says it has paused deposits and withdrawals after an external fund manager ...

When I introduced Steven Pinker, it felt like our worldviews couldn't have been more different. Here's why that dissonance was exactly the point.

It's a plot device beloved by science fiction: our entire universe might be a simulation running on some advanced ...

Abstract: This paper proposes a new active noise control (ANC) system based on a recursive least-squares lattice (RLSL) algorithm by designing secondary-path innovation (SPI) and lattice-order ...

Abstract: This article studies the recursive state estimator-based fuzzy adaptive control scheme for discrete-time uncertain nonlinear systems with state saturations and missing measurements. A fuzzy ...